List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 98 studies with search of: calcium acetate
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients
Conditions: Calcinosis;   Arteriosclerosis;   Hyperparathyroidism, Secondary
Interventions: Drug: calcium acetate;   Drug: sevelamer;   Drug: atorvastatin
2 Completed Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers
Condition: Hyperphosphatemia
Interventions: Drug: Calcium Acetate Oral Solution 667 mg per 5 mL;   Drug: Calcium Acetate 667 mg GelCaps;   Dietary Supplement: Calcium Citrate 950 mg Caplets
3 Completed EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)
Conditions: Hyperphosphatemia;   Kidney Failure
Interventions: Drug: calcium acetate;   Drug: placebo
4 Completed Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis
Conditions: Peritoneal Dialysis;   Chronic Kidney Disease
Interventions: Drug: Sevelamer Hydrochloride (Renagel®);   Drug: Calcium acetate (PhosLo® )
5 Not yet recruiting Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate
Conditions: Haemodialyzed Patients;   Hyperphosphatemia
Interventions: Drug: Calcium acetate;   Drug: Sevelamer
6 Completed Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals
Condition: Renal Failure
Interventions: Drug: calcium acetate;   Drug: aluminum hydroxide;   Drug: Sevelamer
7 Completed Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD
Condition: Vascular Diseases
Intervention: Drug: Sevelamer (Renagel), calcium acetate (Phos-ex)
8 Recruiting A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD
Condition: Chronic Kidney Disease
Intervention: Drug: phosphate binder
9 Recruiting Phosphate Kinetic Modeling
Conditions: End Stage Renal Disease;   Hyperphosphatemia
Intervention: Other: Computer algorithm management of hyperphosphatemia
10 Completed Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
Condition: Osteoporosis
Interventions: Drug: Bicalutamide and Calcium/ Vitamin D supplementation;   Drug: LHRH agonists (Goserelin acetate) and Calcium/ Vitamin D supplementation;   Drug: LHRH agonists (Goserelin acetate)
11 Active, not recruiting Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Conditions: Osteoporosis;   Prostate Cancer
Interventions: Dietary Supplement: calcium carbonate;   Dietary Supplement: calcium citrate;   Dietary Supplement: calcium glucarate;   Dietary Supplement: cholecalciferol;   Drug: buserelin;   Drug: calcium gluconate;   Drug: goserelin;   Drug: leuprolide acetate;   Drug: triptorelin;   Drug: zoledronic acid;   Radiation: brachytherapy;   Radiation: radiation therapy
12 Completed Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes
Condition: Haemodialysis
Interventions: Other: Citrate dialysate;   Other: Acetate dialysate
13 Suspended Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: dasatinib;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: etoposide;   Drug: ifosfamide;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: pegaspargase;   Drug: prednisone;   Drug: therapeutic hydrocortisone;   Drug: vincristine sulfate
14 Recruiting Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
Conditions: Leukemia;   Lymphoma
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: mitoxantrone hydrochloride;   Drug: prednisolone;   Drug: therapeutic hydrocortisone;   Drug: thioguanine;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
15 Recruiting Pegasparaginase or Asparaginase and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Drug/Agent Toxicity by Tissue/Organ;   Leukemia
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: dexamethasone;   Drug: dexrazoxane hydrochloride;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: pegaspargase;   Drug: prednisolone;   Drug: therapeutic hydrocortisone;   Drug: vincristine sulfate;   Radiation: radiation therapy
16 Active, not recruiting Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Conditions: Leukemia;   Lymphoma
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: therapeutic hydrocortisone;   Drug: thiotepa;   Drug: vincristine sulfate
17 Completed Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Biological: filgrastim;   Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: mesna;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: pegaspargase;   Drug: prednisone;   Drug: therapeutic hydrocortisone;   Drug: vincristine sulfate;   Procedure: allogeneic bone marrow transplantation;   Radiation: low-LET cobalt-60 gamma ray therapy;   Radiation: low-LET photon therapy
18 Recruiting Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: etoposide;   Drug: lestaurtinib;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: pegaspargase;   Drug: prednisone;   Drug: therapeutic hydrocortisone;   Drug: vincristine sulfate
19 Terminated Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma
Condition: Lymphoma
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: prednisolone;   Drug: thioguanine;   Drug: vincristine sulfate;   Procedure: radiation therapy
20 Active, not recruiting Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
Conditions: Drug/Agent Toxicity by Tissue/Organ;   Leukemia;   Lymphoma
Interventions: Biological: filgrastim;   Biological: rituximab;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: prednisone;   Drug: rasburicase;   Drug: therapeutic hydrocortisone;   Drug: vincristine sulfate

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services